小青龙汤离子导入联合西药治疗外寒内饮型慢性阻塞性肺疾病急性加重期临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:

温州市科技计划项目(Y20190730)


Clinical Study on Ion Introduction with Xiaoqinglong Decoction Combined with West⁃ ern Medicine for Acute Exacerbation of Chronic Obstructive Pulmonary Disease of Exterior Cold with Interior Fluid Retention Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察小青龙汤离子导入联合西药雾化治疗外寒内饮型慢性阻塞性肺疾病急性加重 期(AECOPD) 的临床疗效。方法:选取外寒内饮型AECOPD 患者78 例,按随机信封法分为对照组和观察组 各39 例。对照组给予布地奈德混悬液、吸入用复方异丙托溴铵溶液、注射用哌拉西林钠他唑巴坦钠治疗,观 察组在对照组基础上加用小青龙汤离子导入治疗。比较2 组临床疗效和安全性,以及治疗前后症状积分、白细 胞计数(WBC)、C-反应蛋白(CRP)、降钙素原(PCT)、呼出气一氧化氮(FeNO)、肺功能指标[用力肺活 量(FVC)、第1 秒用力呼气容积(FEV1)、FEV1/FVC]、血气分析指标[动脉氧分压(PaO2) 和动脉二氧化碳 分压(PaCO2)]、慢性阻塞性肺疾病评分(CAT)、MMRC 呼吸困难评分(mMRC)。结果:观察组总有效率为 94.9%,对照组为79.5%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组喘息、咳嗽、咳痰评分及总 分均较治疗前降低(P<0.05),且观察组上述各项评分均低于对照组(P<0.05)。治疗后,2 组FEV1、FVC 水 平均较治疗前升高(P<0.05),且观察组FVC 水平高于对照组(P<0.05),但2 组FEV1 水平比较,差异无统 计学意义(P>0.05);2 组FEV1/FVC 水平治疗前后比较,差异无统计学意义(P>0.05)。治疗后,2 组 WBC、CRP、PCT、FeNO 水平均较治疗前降低(P<0.05),且观察组CRP、PCT、FeNO 水平均低于对照 组(P<0.05);但2 组WBC 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组PaO2 水平较治疗前升 高(P<0.05),PaCO2 水平较治疗前降低(P<0.05);且观察组PaO2 水平高于对照组(P<0.05),PaCO2 水平 低于对照组(P<0.05)。治疗后,2 组CAT、mMRC 评分较治疗前降低(P<0.05),且观察组CAT、mMRC 评 分均低于对照组(P<0.05)。治疗过程中,2 组血常规、尿常规、肝肾功能及心电图均未出现异常,观察组出 现局部皮肤轻度瘙痒1 例。结论:小青龙汤离子导入联合西药治疗外寒内饮型AECOPD 可有效改善临床症 状、肺功能及血气状态,减轻炎症反应,且安全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of ion introduction with Xiaoqinglong Decoction combined with western medicine atomization for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) of exterior cold with interior fluid retention type. Methods: A total of 78 cases of AECOPD patients of exterior cold with interior fluid retention type were selected and divided into the control group and the observation group according to the random envelope method,with 39 cases in each group. The control group was treated with Budesonide Suspension,Compound Ipratropium Bromide Solution for Inhalation, and Piperacillin Tazobactam Sodium for Injection, and the observation group was additionally treated with ion introduction with Xiaoqinglong Decoction based on the treatment of the control group. Syndrome scores,white blood cell count (WBC),C-reactive protein (CRP),procalcitonin (PCT),fractional exhaled nitric oxide (FeNO),lung function indicators [forced vital capacity (FVC),forced expiratory volume in one second (FEV1) and FEV1/FVC], blood gas analysis indicators [arterial oxygen partial pressure (PaO2) and arterial carbon dioxide partial pressure (PaCO2)],scores of COPD Assessment Test (CAT),and scores of modified Medical Research Council (mMRC) Dyspnoea Scale before and after treatment as well as the clinical effect and safety were compared between the two groups. Results: The total effective rate was 94.9% in the observation group and 79.5% in the control group,the inter group comparison showed that the difference being significant (P<0.05). After treatment, the scores of wheezing, coughing, expectoration, and total scores in the two groups were decreased when compared with those before treatment (P<0.05),and the above scores in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of FEV1 and FVC in the two groups were increased when compared with those before treatment (P<0.05),and the FVC level in the observation group was higher than that in the control group (P<0.05);there was no significant difference being found in the comparison of FEV1 levels between the two groups (P>0.05). There was no significant difference being found in the comparison of FEV1/FVC levels between the two groups before and after treatment (P>0.05). After treatment,the levels of WBC,CRP,PCT,and FeNO in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of CRP,PCT,and FeNO in the observation group were lower than those in the control group (P<0.05);there was no significant difference being found in the comparison of WBC levels between the two groups (P>0.05). After treatment,the PaO2 levels in the two groups were increased when compared with those before treatment (P<0.05),and the PaCO2 levels were decreased when compared with those before treatment (P<0.05);the PaO2 level in the observation group was higher than that in the control group (P<0.05),and the PaCO2 level was lower than that in the control group (P<0.05). After treatment, the CAT and mMRC scores in the two groups were decreased when compared with those before treatment (P<0.05),and the CAT and mMRC scores in the observation group were lower than those in the control group (P<0.05). During the treatment process, there were no abnormality in blood routine, urine routine, liver and kidney function, and electrocardiogram in the two groups. In the observation group, there was one case of mild local skin itching. Conclusion: Ion introduction with Xiaoqinglong Decoction combined with western medicine atomization for AECOPD of exterior cold with interior fluid retention type can effectively improve clinical symptoms,lung function,and blood gas status of patients,reduce inflammatory reactions,and have acceptable safety.

    参考文献
    相似文献
    引证文献
引用本文

俞宁宁,杨欢欢,曾余丰.小青龙汤离子导入联合西药治疗外寒内饮型慢性阻塞性肺疾病急性加重期临床研究[J].新中医,2023,55(22):13-18

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-28
  • 出版日期:
文章二维码